<DOC>
	<DOCNO>NCT02411903</DOCNO>
	<brief_summary>The investigator team find presence dynamic change Clopidogrel resistance associate genetic factor . Currently , study moderate dos statins dynamic Clopidogrel resistance report , therefore study observe 160 case open prospective secondary prevention patient cerebral infarction . Excluded : patient occur Clopidogrel resistance slow metabolism cause cytochrome P450 isoenzyme 2C19（CYP2C19 , observe impact cytochrome P450 isoenzyme 3A4 （CYP3A4）-metabolized non-cytochrome P450 isoenzyme 3A4 （CYP3A4）—metabolized statin dynamically Clopidogrel resistance next 9 month , adverse event record , metabolite clopidogrel（H4 ）and polymorphism cytochrome P450 isoenzyme 2C19 （CYP2C19）/cytochrome P450 isoenzyme 3A4 （CYP3A4）/ cytochrome P450 isoenzyme 2C9（CYP2C9）will detect . Expected Result : patient use cytochrome P450 isoenzyme 3A4（CYP3A4）-metabolized statin result dynamic Clopidogrel resistance easily , H4 level decline , Clopidogrel resistance relate polymorphism cytochrome P450 isoenzyme 3A4 （CYP3A4） .</brief_summary>
	<brief_title>The Dynamic Effect Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins Clopidogrel Resistance Patients With Cerebral Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>The patient must sign informed consent document indicate understand purpose procedure require study willing participate study . Age ＜85 year &gt; 45 year , Male female . The patient Cerebral infarction one month . national institute health stroke scale（NIHSS）score ≤23 point . Blood Platelet count great 150×10^9／L , Less 500×10^9／L . The patient never take aspirin 、dipyridamole、clopidogrel , patient take antiplatelet drug discontinue two week least . The patient never take Statins patient stop taking statins 2 week two week . Allergic constitution , allergic composition drug study . national institute health stroke scale（NIHSS） score ＞23 point . Atrial fibrillation cardiogenic cerebral embolism . Patients undergone surgery trauma ( include fracture ) within past three month . Patients know dysfunction vital organ suffer Serious cardiovascular disease ，or coagulation disorder . The patient take Proton pump inhibitor recently . The history data collection followup process save .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clopidogrel-drug interaction</keyword>
</DOC>